SEC Comment Letter 0000000000-23-009628 to T2 Biosystems, Inc. (TTOO) (CIK 0001492674)
T2 Biosystems, Inc. (TTOO) (CIK 0001492674)
Date: Aug. 31, 2023 · CIK: 0001492674 · Accession: 0000000000-23-009628
AI Filing Summary & Sentiment
File numbers found in text: 333-274182
Letter
United States securities and exchange commission logo August 31, 2023 John Sperzel President, Chief Executive Officer and Chairman of the Board T2 Biosystems, Inc. 101 Hartwell Avenue Lexington, MA 02421 Re:T2 Biosystems, Inc. Registration Statement on Form S-3 Filed August 24, 2023 File No. 333-274182 Dear John Sperzel: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Evan Smith, Esq.
Show Raw Text
United States securities and exchange commission logo
August 31, 2023
John Sperzel
President, Chief Executive Officer and Chairman of the Board
T2 Biosystems, Inc.
101 Hartwell Avenue
Lexington, MA 02421
Re:T2 Biosystems, Inc.
Registration Statement on Form S-3
Filed August 24, 2023
File No. 333-274182
Dear John Sperzel:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Conlon Danberg at 202-551-4466 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Evan Smith, Esq.